Clinical Trials Browser

Phase 2 × OTHER × Single Photon Emission Computed Tomography Computed Tomography × Clear all

NCT05239533 2026-01-14

Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

Phase 2 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms